Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells

PURPOSE: This study was designed to investigate whether vascular smooth muscle cells (VSMC) from the neointima showed any different response to anti-proliferative agents, such as rapamycin or imatinib mesylate, compared to VSMCs from normal artery. MATERIALS AND METHODS: Intimal hyperplasia was made...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yang Jin, Min, Sang-Il, Jung, In Mok, Lee, Taeseung, Ha, Jongwon, Chung, Jung Kee, Kim, Sang Joon, Min, Seung-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Vascular Specialist International 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480304/
https://www.ncbi.nlm.nih.gov/pubmed/26217609
http://dx.doi.org/10.5758/vsi.2014.30.1.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480304/
https://www.ncbi.nlm.nih.gov/pubmed/26217609
http://dx.doi.org/10.5758/vsi.2014.30.1.5

Ejemplares similares